HIKMA PHARMACEUTIC.LS-,10 financial statements, including revenue, expenses, and profit

The total revenue of H5P for the last semiannual is 1.46 B EUR, and it's 0.38% lower compared to the previous semiannual. The net income of H2 24 is 124.52 M EUR.